The p38 mitogen‐activated protein kinase regulates effector functions of primary human CD4 T cells
Open Access
- 6 December 2005
- journal article
- leukocyte signaling
- Published by Wiley in European Journal of Immunology
- Vol. 35 (12) , 3631-3642
Abstract
The role of p38 mitogen‐activated protein kinase in primary human T cells is incompletely understood. We analyzed in detail the role of p38 in the regulation of effector functions and differentiation of human CD4 T cells by using a p38‐specific inhibitor and a dominant‐negative mutant of p38. p38 was found to mediate expression of IL‐10 and the Th2 cytokines IL‐4, IL‐5, and IL‐13 in both, primary naive and memory T cells. In contrast, inhibition of p38 activity did not affect expression of the Th1 cytokines IFN‐γ and TNF induced by TCR‐stimulation, but decreased IL‐12‐mediated IFN‐γ expression. Cytokine expression from established Th2 effector cells was also regulated by p38, however, the role of p38 was less pronounced compared to primary CD4 T cells. p38 MAPK regulated cytokine gene expression at both, the transcriptional level by activating gene transcription and the post‐transcriptional level by stabilizing cytokine mRNA. As a result of the effect of p38 on IL‐4 expression, p38 activity modulated differentiation of naive precursor T cells by inducing a shift of the Th1/Th2 balance toward the immuno‐modulatory Th2 direction. Together, the data suggest that p38 plays a key role in human Th2 cell immune responses.Keywords
This publication has 49 references indexed in Scilit:
- Stabilization of IFN-γ mRNA by MAPK p38 in IL-12– and IL-18–stimulated human NK cellsBlood, 2005
- Regulation of the Maintenance of Peripheral T-Cell Anergy by TAB1-Mediated p38α ActivationMolecular and Cellular Biology, 2004
- GATA-3 in Human T Cell Helper Type 2 DevelopmentJournal of Experimental Medicine, 2004
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- Nuclear Factor of Activated T Cells c Is a Target of p38 Mitogen-Activated Protein Kinase in T CellsMolecular and Cellular Biology, 2003
- Regulation of IL4 gene expression by T cells and therapeutic perspectivesNature Reviews Immunology, 2003
- Regulation of tumour necrosis factor α mRNA stability by the mitogen‐activated protein kinase p38 signalling cascadeFEBS Letters, 2000
- Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism.Journal of Clinical Investigation, 1997
- SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1FEBS Letters, 1995
- Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells.Journal of Experimental Medicine, 1990